Second Line Chemotherapy with 5 Fluorouracil and Vinorelbine in Anthracycline and Taxane Pretreated Patients with Metastatic Breast Cancer

Cancer Investigation

Volumn 22, Issue 1, 2004, Pages 10-15

  Razis, Evangelia ^a   Kosmidis, Paris ^a   Aravantinos, Gerassimos ^b   Bakoyiannis, Charalambos ^a   Janinis, Jim ^b   Timotheadou, Helen ^c   Christodoulou, Christos ^d   Fountzilas, George ^c  

^a HYGEIA HOSPITAL   (Greece)

^b AGII ANARGIRI CANCER HOSPITAL   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d Henry Dynan Hospital   (Greece)

Author keywords

5 Fluorouracil; Metastatic breast cancer; Palliation; Vinorelbine

Indexed keywords

ANTHRACYCLINE; DOCETAXEL; FLUOROURACIL; FOLINIC ACID; NAVELBINE; PACLITAXEL; TAXANE DERIVATIVE; TRASTUZUMAB;

ADULT; AGED; ALOPECIA; ANEMIA; ANOREXIA; ARTHRALGIA; ARTICLE; BLEEDING; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; DIARRHEA; DIZZINESS; DRUG RESPONSE; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; FEVER; FOLLOW UP; HAND FOOT SYNDROME; HUMAN; INFECTION; LEUKOPENIA; LIVER TOXICITY; METASTASIS; MUCOSA INFLAMMATION; MULTICENTER STUDY; MYALGIA; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; ONYCHOLYSIS; PALLIATIVE THERAPY; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SIDE EFFECT; SKIN DISEASE; STOMATITIS; THROMBOCYTOPENIA; TREATMENT OUTCOME; VEIN THROMBOSIS; VOMITING; WEIGHT REDUCTION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MIDDLE AGED; NEOPLASM METASTASIS; SALVAGE THERAPY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINBLASTINE;

EID: 1942441577     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-120027576     Document Type: Article

References (19)

1. Lobert, S.; Volveric, B.; Correia, J.J. Interaction of vinca alkaloids with tubulin: a comparison of vinblastine, vincristine and vinorelbine. Biochemistry 1996, 35 (21), 6806-6814.
2. Terenziani, M.; Demicheli, R.; Brambilla, C.; Ferrari, L.; Molinterni, A.; Zambetti, M.; Caranceni, A.; Martini, C.; Bonadonna, G. Vinorelbine: an active, non-cross-resistant drug in advanced breast cancer: results from a phase II study. Breast Cancer Res. Treat. 1996, 39, 285-291.
3. Weber, B.L.; Vogel, C.L.; Jones, S.; Harvey, H.; Hutchins, L.; Bigley, J.; Hohneker, J. Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer. J. Clin. Oncol. 1995, 13, 2722-2730.
4. Hegg, R.; Costa, M.A.; Perdicaris, M.; Delgado, G.L.; Cabral-Filho, S.; Malzyner, A.; Caponero, R.; Yamagushi, N.; Norzes, N.; Anelli, A.; Correa, M.; Nader, L.; Andrade, C. A phase II fractionated vinorelbine/doxorubicin as first line therapy for advanced breast cancer. Curr. Med. Res. Opin. 2001, 16 (4), 225-234.
5. Campone, M.; Fumoleau, P.; Delecroix, V.; Deporte-Fety, R.; Perrocheau, G.; Vernillet, L.; Borg-Olivier, O.; Louboutin, J.P.; Bisser, M.C.; Rua, A.; Azli, N. Phase I, dose finding Pharmacokinetic study of docetaxel and vinorelbine as first line chemotherapy for metastatic breast cancer. Ann. Oncol. 2001, 12 (7), 909-918.
6. Hortobagyi, N. Treatment of advanced breast cancer with gemcitabine and vinorelbine. Oncology (Huntingt.) 2001, 15 (2 Suppl. 3), 15-17.
7. Dieras, V.; Extra, J.M.; Bellissant, E.; Espie, M.; Morran, F.; Piery, J.Y.; Mignot, L.; Tresca, P.; Marly, M. Efficacy and tolerance of vinorelbine and fluorouracil combination as first-line chemotherapy of advanced breast cancer: results of a phase II study using a sequential group method. J. Clin. Oncol. 1996, 14, 3097-3104.
8. Berruti, A.; Sperone, P.; Bottini, A.; Gorzegno, G.; Lorusso, V.; Brunelli, A.; Botta, H.; Tampelun, M.; Donadio, M.; Mancarella, S.; Delena, M.; Alquatti, P.; Dogliotti, L. Phase II study of vinorelbine with protracted fluorouracil infusion as a second or third-line approach for advanced breast cancer patients previously treated with anthracyclines. J. Clin. Oncol. 2000, 18, 3370-3377.
9. Nole, F.; de Braud, F.; Aapro, M.S.; Minchella, I.; De Pay, M.; Zampino, M.G.; Monti, S.; Andreoni, G.; Goldhirsh, A. Phase I-II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: a regimen with a low subjective toxic burden. Ann. Oncol. 1997, 8, 865-870.
10. Kornek, G.V.; Haider, K.; Kwasny, W.; Lang, F.; Krauss, B.; Hejna, M.; Raderer, M.; Neinlander, G.; Depisch, G.; Shuthauer, W. Effective treatment of advanced breast cancer with vinorelbine, 5-fluorouracil and 1-leucovorin plus human granulocyte colony-stimulating factor. Br. J. Cancer 1998, 78, 673-678.
11. Zambelli, A.; della Cuna, F.S.R.; Ponchio, L.; Ucci, G.; Da Prada, G.A.; Robustelli della Cuna, G. Four day infusion of fluorouracil plus vinorelbine as salvage treatment of heavily pretreated metastatic breast cancer. Breast Cancer Res. Treat. 2000, 61, 242-247.
12. Lombardi, D.; Magri, M.D.; Crivellari, D.; Spazzapan, S.; Paolello, C.; De Cicco, M.; Di Lauro, V.; Scuderi, C.; Veronesi, A. Combination chemotherapy with Navelbine and continuous infusion 5-Flurouracil in metastatic, chemotherapy refractory breast cancer. Ann. Oncol. 2000, 61 (8), 1041-1043.
13. Zambetti, M.; Demichelli, R.; De Candis, D.; Antonelli, G.; Giacobone, A.; Terenziani, M.; Lafranchi, A.; Garbagnati, F.; Biasi, S.; Bonadonna, G. Five day infusion fluorouracil plus vinorelbine IV in metastatic pretreated breast cancer patients. Breast Cancer Res. Treat. 1977, 44 (3), 255-260.
14. Nole, F.; Minchella, I.; Colleoni, M.; Orvietti, E.; Munzone, E.; DeBrand, F.; Peruzzotti, G.; Martinelli, G.; Zampino, M.G.; Catania, C.; Pizzamiglio, M.; Veronesi, P.; Zurrida, S.; Galimberti, V.; Goldhirsh, A.; Veronesi, U. Primary chemotherapy in operable breast cancer with favorable prognostic factors: a pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid. Ann. Oncol. 1999, 10, 993-996.
15. WHO Handbook for Reporting Results of Cancer Treatment. World Health Organisation Offset Publication No. 48: Geneva, Switzerland, 1979.
16. Miller, A.B.; Hogestraeten, B.; Staquet, M.; Winklet, A. Reporting results of cancer treatment. Cancer 1981, 47, 207-214.
17. Fumoleau, P.; Deporte, R.; Kerbrat, P.; Laguerre, B. UFT/leucovorin plus vinorelbine combination for advanced breast cancer. Oncology (Huntingt.) 1999, 13 (7 Suppl. 3), 86-90.
18. Cardoso, F.; Dileo, A.; Lohrisch, C.; Bernard, C.; Ferreira, F.; Piccart, M.S. Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades. Ann. Oncol. 2002, 13, 197-207.
19. Rivera, E.; Sutton, L.; Colwell, B.; Graham, M.; Frye, D.; Sommeville, M.; Conklin, H.S.; McGuirt, C.; Levin, J.; Hortobagyi, G.N. Multicenter phase II study of a 28-day regimen of orally administered eniluracil and fluorouracil in the treatment of patients with anthracycline and taxane resistant advanced breast cancer. J. Clin. Oncol. 2002, 20, 987.